{"filing":{"accession_number":"0001493152-26-038436","cik":"0001595353","ticker":"GLMD","company_name":"Galmed Pharmaceuticals Ltd.","form":"6-K","filing_date":"2026-08-14","report_date":"2026-08-14","primary_document":"form6-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1595353/000149315226038436/form6-k.htm"},"events":[{"id":27957,"run_id":25534,"accession_number":"0001493152-26-038436","anchor_item_number":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"The 6-K announces a 1-for-8 reverse stock split of Galmed's ordinary shares, effective August 19, 2026, reducing outstanding shares from approximately 8.3 million to 1.04 million. While a reverse split is a capital structure event with governance implications, it does not fit the specific event types (exec changes, M\u0026A, debt, dilution, etc.). This is a material governance/capital structure action that would affect a reasonable investor's assessment of share count, trading mechanics, and potential delisting-risk mitigation, making it a governance_other event.","company_name":"Galmed Pharmaceuticals Ltd.","ticker":"GLMD","filing_date":"2026-08-14","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":29690,"accession_number":"0001493152-26-038436","item_number":null,"item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The 6-K announces a 1-for-8 reverse stock split of Galmed's ordinary shares, effective August 19, 2026, reducing outstanding shares from approximately 8.3 million to 1.04 million. While a reverse split is a capital structure event with governance implications, it does not fit the specific event types (exec changes, M\u0026A, debt, dilution, etc.). This is a material governance/capital structure action that would affect a reasonable investor's assessment of share count, trading mechanics, and potential delisting-risk mitigation, making it a governance_other event.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-14T20:36:45.425537+00:00","company_name":"Galmed Pharmaceuticals Ltd.","ticker":"GLMD","filing_date":"2026-08-14"}]}